IMAVITA – new member
IMAVITA is an innovating contract research organization (CRO) proposing preclinical services in the exploration of preclinical models of human pathologies
Read more4th edition Bioproduction of Immunotherapies
The 4th edition of the Bioproduction of Immunotherapies co-organized by MabDesign and Medicen Paris Region took place at Biocitech on September 24th 2019.This growing event gathered together more than 130 participants from over 90 companies to discuss and learn more about the latest innovations on the Immunotherapies Bioproduction.
Read more7th Antibody Industrial Symposium AIS2019
The 7th edition of the Antibody Industrial Symposium AIS2019 was held on June 24th & 25th 2019 in the Vinci International Convention Centre of Tours.This growing event was this year dedicated to “Harnessing the Immune System with Therapeutic Antibodies” major theme chosen by the Scientific Advisory Board. The AIS2019 allowed to gather +350 attendees from start-ups, SME, big industrials & academics based in more than 15 different countries with the will to exchange and make advance the therapeutic antibody field.
Read moreMABDESIGN and REGIMBEAU announce strategic partnership
MABDESIGN has signed a partnership agreement with REGIMBEAU, an intellectual property law firm. This new agreement, in line with MABDESIGN’s strategy to expand its range of business support services, will allow the organization to propose a one-stop-shop offer across all intellectual property domains as applied to biopharmaceuticals.
Read moreIntelligence Artificielle & Développement des Immunothérapies
MabDesign and Lyonbiopole organized a day dedicated to the use of Artificial Intelligence to accelerate the development of Immunotherapies. This event gathered together nearly 80 stakeholders working in Artificial Intelligence applied to health.
Read more